Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Patient Access Pulse by Pelitas: Engaging iPAS Version 10 for Interoperability

As healthcare revolutionizes to meet interoperability needs, so does the technology. iPAS Version 10 (v10) is one data management tool driving the transformation. Kristine Anderson, Vice President of Solutions Management at Pelitas, and Tracy Eckerman, Associate Vice President of Technical Solutions Management, met with host Tyler Kern to explain exactly how. The pandemic accelerated tech…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

As healthcare revolutionizes to meet interoperability needs, so does the technology. iPAS Version 10 (v10) is one data management tool driving the transformation. Kristine Anderson, Vice President of Solutions Management at Pelitas, and Tracy Eckerman, Associate Vice President of Technical Solutions Management, met with host Tyler Kern to explain exactly how.

The pandemic accelerated tech too creation to meet various healthcare needs, such as patient access, telehealth, and virtual intake. The virtual intake medicine suite was one of the first products iPAS v10 launched; it involves the patient so they are an active participant in their care management.

While helpful, the variety of tools has presented challenges, creating siloed data if not properly integrated. “Interoperability is going to be absolutely critical in this next year for being able to leverage all of those tools,” explained Eckerman. Next year, the plan is to deepen integration opportunities. “It’s really going to be exciting to build on what we’ve already done and take the product to the next level,” said Anderson.

Anderson provided the definition of data management, stating that it is “the practice of collecting, keeping, and using data securely, cost-effectively, and efficiently.’” Collecting data seems basic, but what data needs to be collected varies by patient. It must be stored in the EHR without extra steps and used effectively to easily manipulated reports that track trends.

Looking forward, where does the ultimate answer in healthcare data management lie? “Digital transformation maturity doesn’t happen overnight but getting the right data in the right system and working with the right people will drive organizational transformation and help our clients improve their business processes in patient access,” Eckerman summarized.

Head to pelitas.com for insight into iPAS v10 and subscribe to Patient Access Pulse to keep up with the latest topics

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Gene therapies, early detection, and GLP-1 drugs are reshaping enterprise healthcare procurement

Gene therapies, early detection, and GLP-1 drugs are reshaping enterprise healthcare procurement

Recent advancements in healthcare, including gene therapies, early detection methods, and GLP-1 drugs, are influencing enterprise healthcare procurement strategies. These innovations are impacting benefit plan adjustments and procurement decision-making processes. The healthcare industry is experiencing a notable shift due to FDA-cleared treatments and predictive diagnostics.

  • 01Gene therapies and early detection methods are transforming healthcare procurement.
  • 02FDA-cleared treatments are prompting shifts in benefit plans.
  • 03Advancements are accelerating decision-making in healthcare procurement.

Jul 14, 2026

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

UpDoc has received FDA clearance for its LLM-driven diabetes management app, while Aidoc has been granted breakthrough device status for its AI-drafted radiology reports. This marks a significant milestone as clinical AI applications continue to gain regulatory approval and recognition. The advancements showcase the potential of AI in improving healthcare management and diagnostic processes.

  • 01UpDoc's diabetes management app receives FDA clearance.
  • 02Aidoc achieves breakthrough device status for AI radiology reports.
  • 03Regulatory milestones highlight AI's growing role in healthcare.

Jul 13, 2026

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

The chief data and AI officer at Cedars-Sinai discusses the evolving role of AI in healthcare. While the first wave of AI focused on enhancing productivity, the second wave is expected to transform job roles and the workforce structure. This shift indicates a deeper integration of AI technology in healthcare operations.

  • 01First wave of AI increased productivity in healthcare.
  • 02Second wave aims to restructure job roles.
  • 03AI will deeply integrate into healthcare operations.

Jul 13, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512